Fuan Pharmaceutical's declining revenue performance, weak sh...
Fuan Pharmaceutical's declining revenue performance, weak share price, and lower-than-industry growth rates are likely causing its suppressed P/S ratio. These factors may continue to impact the share price unless conditions improve.
Fuan Pharmaceutical (Group) Co., Ltd. (SZSE:300194) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment